Department of Chinese Integrative Medicine Oncology, The First Affiliated Hospital of Anhui Medical University, 230022, Hefei, Anhui, China.
Department of Integrative Oncology, Fudan University Shanghai Cancer Center, 200032, Shanghai, China.
BMC Cancer. 2023 Feb 10;23(1):139. doi: 10.1186/s12885-023-10597-9.
The immunotherapy efficacy on pancreatic cancer remains unsatisfactory. Therefore, it is still necessary to further clarify the pancreatic immune cell infiltration and search for immune-related prognostic indicators. We analyzed the 135 pancreatic cancer patients' data retrieved from the TCGA database for the immune cell infiltration, tumor microenvironment score and the correlation of the immune cells, followed by identification of prognostic immune clusters and genes clusters. The R language was used for the immune score calculation, and immune cells proportion related survival differences identification. The function of immune cells was verified through datasets in the GEO database and in vivo experiments. The results showed that M0 Macrophages had negative relations to CD8 + T cells and immune scores. There were differences in median survival in ICI clusters, gene clusters, and immune score groups (p < 0.05). M0 macrophages accounted for more than 9.8%, indicating a poor prognosis, while T cells accounted for more than 9.2%, indicating a good prognosis. In vivo results showed that M0 macrophages promote pancreatic cancer growth. Elimination of M0 macrophages may be a hopeful strategy against pancreatic cancer.
免疫疗法治疗胰腺癌的效果仍不尽人意。因此,仍有必要进一步阐明胰腺免疫细胞浸润情况,并寻找与免疫相关的预后指标。我们分析了从 TCGA 数据库中检索到的 135 例胰腺癌患者的数据,以评估免疫细胞浸润、肿瘤微环境评分以及免疫细胞的相关性,随后确定与预后相关的免疫簇和基因簇。使用 R 语言计算免疫评分,并通过 GEO 数据库和体内实验验证免疫细胞的功能。结果表明,M0 巨噬细胞与 CD8+T 细胞和免疫评分呈负相关。ICI 聚类、基因聚类和免疫评分组的中位生存时间存在差异(p<0.05)。M0 巨噬细胞占比超过 9.8%,提示预后不良,而 T 细胞占比超过 9.2%,提示预后良好。体内结果表明,M0 巨噬细胞促进胰腺癌的生长。消除 M0 巨噬细胞可能是一种有希望的治疗胰腺癌的策略。